Thymidine kinase 1 upregulation is an early event in breast tumor formation

Journal of Oncology

Volumn , Issue , 2012, Pages

  Alegre, Melissa M ^a   Robison, Richard A ^a   O'Neill, Kim L ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDINE KINASE 1;

ARTICLE; BREAST CARCINOMA; BREAST HYPERPLASIA; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; TISSUE MICROARRAY; UPREGULATION;

EID: 84863688495     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/575647     Document Type: Article

References (20)

1. Stuart-Harris R., Caldas C., Pinder S. E., Pharoah P., Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients Breast 2008 17 4 323 334
2. Mukhtar R. A., Moore A. P., Nseyo O., Baehner F. L., Au A., Moore D. H., Twomey P., Campbell M. J., Esserman L. J., Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity Breast Cancer Research and Treatment 2011 130 2 635 644
3. Nikolényi A., Uhercsk G., Csenki M., Hamar S., Csrgo E., Tnczos E., Thurz L., Brodowicz T., Wagnerova M., Kahn Z., Tumour topoisomerase II alpha protein expression and outcome after adjuvant dose-dense anthracycline-based chemotherapy Pathology and Oncology Research 2011 18 1 61 68
4. Mao Y., Wu J., Wang N., He L., Wu C., He Q., Skog S., A comparative study: immunohistochemical detection of cytosolic thymidine kinase and proliferating cell nuclear antigen in breast cancer Cancer Investigation 2002 20 7-8 922 931 (Pubitemid 35315926)
5. Gasparri F., Wang N., Skog S., Galvani A., Eriksson S., Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan assays European Journal of Cell Biology 2009 88 12 779 785
6. Hengstschlger M., Pfeilstcker M., Wawra E., Thymidine kinase expressiona marker for malignant cells Advances in Experimental Medicine and Biology 1998 431 455 460
7. Mikulits W., Hengstschlger M., Sauer T., Wintersberger E., Mllner E. W., Overexpression of thymidine kinase mRNA eliminates cell cycle regulation of thymidine kinase enzyme activity Journal of Biological Chemistry 1996 271 2 853 860 (Pubitemid 26034937)
8. Nisman B., Yutkin V., Nechushtan H., Gofrit O. N., Peretz T., Gronowitz S., Pode D., Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy Urology 2010 76 2 513.e1 513.e6
9. Nisman B., Allweis T., Kaduri L., Maly B., Gronowitz S., Hamburger T., Peretz T., Serum thymidine kinase 1 activity in breast cancer Cancer Biomarkers 2010 7 2 65 72
10. Li Z., Wang Y., He J., Ma J., Zhao L., Chen H., Li N., Zhou J., He E., Skog S., Serological thymidine kinase 1 is a prognostic factor in oesophageal, cardial and lung carcinomas European Journal of Cancer Prevention 2010 19 4 313 318
11. Svobodova S., Topolcan O., Holubec L., Treska V., Sutnar A., Rupert K., Kormunda S., Rousarova M., Finek J., Prognostic importance of thymidine kinase in colorectal and breast cancer Anticancer Research 2007 27 4 A 1907 1909 (Pubitemid 46954696)
12. He Q., Fornander T., Johansson H., Johansson U., Hu G. Z., Rutqvist L. E., Skog S., Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer Anticancer Research 2006 26 6 4753 4759 (Pubitemid 46032108)
13. O'Neill K. L., Hoper M., Odling-Smee G. W., Can thymidine kinase levels in breast tumors predict disease recurrence? Journal of the National Cancer Institute 1992 84 23 1825 1828
14. Foekens J. A., Romain S., Look M. P., Martin P. M., Klijn J. G. M., Thymidine kinase and thymidylate synthase in advanced breast cancer: Response to tamoxifen and chemotherapy Cancer Research 2001 61 4 1421 1425 (Pubitemid 34292567)
15. He E., Xu X. H., Guan H., Chen Y., Chen Z. H., Pan Z. L., Tang L. L., Hu G. Z., Li Y., Zhang M., Zhou J., Eriksson S., Fornander T., Skog S., Thymidine kinase 1 is a potential marker for prognosis and monitoring the response to treatment of patients with breast, lung, and esophageal cancer and non-Hodgkin's lymphoma Nucleosides, Nucleotides and Nucleic Acids 2010 29 46 352 358
16. He Q., Mao Y., Wu J., Decker C., Merza M., Wang N., Eriksson S., Castro J., Skog S., Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas International journal of oncology 2004 25 4 945 953
17. Guan H., Sun Y., Zan Q., Xu M., Li Y., Zhou J., He E., Eriksson S., Wen W., Skog S., Thymidine kinase 1 expression in atypical ductal hyperplasia significantly differs from usual ductal hyperplasia and ductal carcinoma in situ: a useful tool in tumor therapy management Molecular Medicine Reports 2009 2 6 923 929
18. Huang S., Lin J., Guo N., Zhang M., Yun X., Liu S., Zhou J., He E., Skog S., Elevated serum thymidine kinase 1 predicts risk of pre/early cancerous progression Asian Pacific Journal of Cancer Prevention 2011 12 2 497 505
19. Votava T., Topolcan O., Holubec L., Cerna Z., Sasek L., Finek J., Kormunda S., Changes of serum thymidine kinase in children with acute leukemia Anticancer Research 2007 27 4 1925 1928 (Pubitemid 46954700)
20. O'Neill K. L., Buckwalter M. R., Murray B. K., Thymidine kinase: diagnostic and prognostic potential Expert Review of Molecular Diagnostics 2001 1 4 428 433 (Pubitemid 34654422)